NASDAQ: NNNN
Anbio Biotechnology Stock Ownership - Who owns Anbio Biotechnology?

Insider buying vs selling

Have Anbio Biotechnology insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNNN insiders and whales buy or sell their stock.

NNNN Shareholders

What type of owners hold Anbio Biotechnology stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Geodec0.00%27$171.18Institution
Geode Capital Management LLC0.00%26$164.84Institution
Bank Of America Corp0.00%13$82.42Institution
Boacrp0.00%13$82.42Institution
Bnppar0.00%12$76.08Institution
Marwac0.00%12$76.08Institution
Bnp Paribas Financial Markets0.00%11$69.74Institution
Marshall Wace LLP0.00%11$69.74Institution
Morgan Stanley0.00%7$44.38Institution
Morsta0.00%7$44.38Institution

1 of 3

NNNN vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNNN0.00%0.00%
AVR0.07%35.05%Net BuyingNet Selling
STAA0.11%84.62%Net BuyingNet Selling
ANGO0.09%24.09%Net SellingNet Selling
KMTS0.04%99.96%Net SellingNet Selling

Anbio Biotechnology Stock Ownership FAQ

Who owns Anbio Biotechnology?

Anbio Biotechnology (NASDAQ: NNNN) is owned by 0.00% institutional shareholders, 0.00% Anbio Biotechnology insiders, and 100.00% retail investors. Geodec is the largest individual Anbio Biotechnology shareholder, owning 27.00 shares representing 0.00% of the company. Geodec's Anbio Biotechnology shares are currently valued at $171.18.

If you're new to stock investing, here's how to buy Anbio Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.